Brooklyn, United States
Aperiam Bio, a biotechnology startup founded in 2021, is carving out a niche in the Health Care industry by leveraging advanced computer vision algorithms to create hyper-folding enzymes. Their distinctive approach enables a deeper understanding of protein chemistry, setting them apart in the realms of Health and Wellness.
With headquarters in the United States, Aperiam Bio touts the slogan, "We Reveal Biology," encapsulating their mission to push the boundaries of biological science and innovation. The company recently secured a $9.00M Seed Round investment on 29 November 2023, backed by notable investors such as Civilization Ventures, KdT Ventures, Axial VC, and OMX Ventures.
The support of these prominent investors underscores a strong confidence in Aperiam Bio's potential to innovate within the biotechnology landscape, which positions them as a compelling opportunity for further investments in the burgeoning field of computational biology.
